Articles

PP02 The histone methyltransferases G9a/GLP: new promising targets for the treatment of multiple myeloma

BJH - volume 8, issue Abstract Book BHS, february 2017

E. De Smedt , J. Devin , H. Liu , A. Maes , dr. K. Maes , K. De Veirman , E. Menu , K. Vanderkerken PhD, J. Moreaux , E. De Bruyne

Read more

PP03 The anaphase-promoting-complex/ cyclosome: a new promising target in mantle cell lymphoma and diffuse large B cell lymphoma

BJH - volume 8, issue Abstract Book BHS, february 2017

A. Maes , E. De Smedt , K. De Veirman , dr. K. Maes , E. Menu , E. Van Valckenborgh PhD, K. Vanderkerken PhD, E. De Bruyne

Read more

P1.09 RASSF4 functions as a tumor suppressor in Multiple Myeloma

BJH - volume 7, issue Abstract Book BHS, january 2016

E. De Smedt , dr. K. Maes , S. Verhulst , C. Heirman , A. Maes , K. Breckpot , L. Van Grunsven , J. Moreaux , E. De Bruyne

Read more

P1.01 Myeloid Derived Suppressor Cells induce Multiple Myeloma cell survival through AMPK activation

BJH - volume 6, issue Abstract Book BHS, january 2015

K. De Veirman , J. van Ginderachter , N. De Beule MD, PhD, S. Lub , A. Maes , E. De Bruyne , E. Menu , I. Van Riet PhD, K. Vanderkerken PhD, E. Van Valckenborgh PhD

Read more
X